188 related articles for article (PubMed ID: 3512612)
1. Cyclosporin and renal graft histology.
d'Ardenne AJ; Dunnill MS; Thompson JF; McWhinnie D; Wood RF; Morris PJ
J Clin Pathol; 1986 Feb; 39(2):145-51. PubMed ID: 3512612
[TBL] [Abstract][Full Text] [Related]
2. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.
Neild GH; Taube DH; Hartley RB; Bignardi L; Cameron JS; Williams DG; Ogg CS; Rudge CJ
J Clin Pathol; 1986 Feb; 39(2):152-9. PubMed ID: 3512613
[TBL] [Abstract][Full Text] [Related]
3. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
[TBL] [Abstract][Full Text] [Related]
4. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
5. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies.
Ruiz P; Kolbeck PC; Scroggs MW; Sanfilippo F
Transplantation; 1988 Jan; 45(1):91-5. PubMed ID: 3276070
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
7. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period.
Klintmalm G; Bohman SO; Sundelin B; Wilczek H
Lancet; 1984 Oct; 2(8409):950-4. PubMed ID: 6149343
[TBL] [Abstract][Full Text] [Related]
8. A comparison of cyclosporin versus azathioprine treatment in renal transplants in Edinburgh.
Notghi A; Dick J; Smith G; Anderton JL; Chisholm GD
Scott Med J; 1989 Jun; 34(3):459-62. PubMed ID: 2665071
[TBL] [Abstract][Full Text] [Related]
9. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.
Versluis DJ; Ten Kate FJ; Wenting GJ; Jeekel J; Weimar W
J Clin Pathol; 1988 May; 41(5):498-503. PubMed ID: 3290264
[TBL] [Abstract][Full Text] [Related]
10. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin.
Farnsworth A; Hall BM; Ng AB; Duggin GG; Horvath JS; Sheil AG; Tiller DJ
Am J Surg Pathol; 1984 Apr; 8(4):243-52. PubMed ID: 6369996
[TBL] [Abstract][Full Text] [Related]
11. Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study.
Sweny P; Lui SF; Scoble JE; Varghese Z; Fernando ON; Moorhead JF
Transpl Int; 1990 May; 3(1):19-22. PubMed ID: 2196060
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of cyclosporin nephrotoxicity after three months' treatment.
Chapman JR; Griffiths D; Harding NG; Morris PJ
Lancet; 1985 Jan; 1(8421):128-30. PubMed ID: 2857212
[TBL] [Abstract][Full Text] [Related]
14. 'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin A.
Hamilton DV; Evans DB; Henderson RG; Thiru S; Calne RY; White DJ; Carmichael DJ
Proc Eur Dial Transplant Assoc; 1981; 18():400-9. PubMed ID: 7036160
[TBL] [Abstract][Full Text] [Related]
15. Renography and biopsy-verified acute rejection in renal allotransplanted patients receiving cyclosporin A.
Thomsen HS; Nielsen SL; Larsen S; Løkkegaard H
Eur J Nucl Med; 1987; 12(10):473-6. PubMed ID: 3552684
[TBL] [Abstract][Full Text] [Related]
16. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation.
Morris PJ; Chapman JR; Allen RD; Ting A; Thompson JF; Dunnill MS; Wood RF
Lancet; 1987 Mar; 1(8533):586-91. PubMed ID: 2881131
[TBL] [Abstract][Full Text] [Related]
18. [Biopsy findings in kidney transplants after treatment with cyclosporin A].
Nizze H; Gokel JM; Lang W; Mihatsch MJ
Zentralbl Allg Pathol; 1986; 132(5-6):423-33. PubMed ID: 3551394
[TBL] [Abstract][Full Text] [Related]
19. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
[No Abstract] [Full Text] [Related]
20. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation.
Pedersen EB; Hansen HE; Kornerup HJ; Madsen S; Sørensen AW
Nephrol Dial Transplant; 1993; 8(3):250-4. PubMed ID: 8385294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
